The entire world has been grappling with the COVID-19 pandemic for some time now, and efforts are on to find a treatment protocol and vaccine. Several drugs and treatment therapies are being tried and tested to find a cure for this pandemic. In the middle of this fervent R&D activity, some questions come to mind — what about IP protection? How would companies commercialise a cure — if and when it is finally found? How would the cure be available to the public en-masse at affordable prices? Enter patent law and the aspect of Licencing.
Continue Reading To Protect or Not to Protect that is the Question : Patent Licensing in times of Covid-19 Pandemic
Shivanshu Bhardwaj
Associate in the Dispute Resolution Practice at the Delhi office of Cyril Amarchand Mangaldas. Shivanshu assists in civil and commercial disputes, as well as corporate advisory. He can be reached at shivanshu.bhardwaj@cyrilshroff.com